Use of ReDS Technology in Patients With Acute Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 240 participants.

Also called NCT04305717

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 240 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04305717
Other papers using this trial's data
  • Remote Dielectric Sensing Before and After Discharge in Patients With ADHF: The ReDS-SAFE HF Trial JACC. Heart failure, 2024-04 DOI, PubMed 38430084

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04305717. Randomized; double masking; primary purpose treatment. Start 2020-08-14 (actual); primary completion 2021-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Use of ReDS Technology in Patients With Acute Heart Failure
Condition
Heart Failure
Condition
Lung Congestion
Intervention (Device)
ReDS-guided strategy
Lead sponsor
Icahn School of Medicine at Mount Sinai (class: other)

Record details

Record id
cardio:ct-nct04305717
Content hash
6e281282fac4df83cc101254d1a1fbc7aa76aca54a4e2b0295c62842f2853aa0